Kanto J, Lindberg R, Pihlajamäki K, Scheinin M
Pharmacol Toxicol. 1987 Feb;60(2):108-9. doi: 10.1111/j.1600-0773.1987.tb01506.x.
Both placental and blood-CSF transfer of atropine (0.01 mg/kg intramuscularly) was measured (by RIA) in 11 parturients undergoing Caesarean section under spinal analgesia. In the foeto-placental unit a significant penetration into amniotic fluid was found, whereas in CSF there was a measurable level of the drug (greater than 1.5 ng/ml) in only one mother. Our results show that there is a fundamental difference in the penetrability of tertiary ammonium alkaloids like atropine through these two biological membranes. However, our results concern penetration into human lumbar CSF and do not necessarily reflect potential penetration into the ventricular CSF, choroid plexus or brain ventricular ependyma.
对11名在脊髓麻醉下接受剖宫产的产妇,测定了(通过放射免疫分析法)阿托品(0.01mg/kg肌肉注射)的胎盘转运和血-脑脊液转运情况。在胎儿-胎盘单位中,发现阿托品可显著渗透至羊水,而在脑脊液中,仅在一名产妇中检测到可测量水平的药物(大于1.5ng/ml)。我们的结果表明,像阿托品这样的叔胺生物碱通过这两种生物膜的穿透性存在根本差异。然而,我们的结果涉及药物穿透人腰段脑脊液的情况,不一定反映其穿透脑室脑脊液、脉络丛或脑室室管膜的潜在能力。